Sep

19

2021

What is first-line treatment in patient with paroxysmal nocturnal hemoglobinuria (PNH)?

By William Aird

A

What is first-line treatment in patient with paroxysmal nocturnal hemoglobinuria (PNH)?

Eculizumab or ravulizumab (C5 inhibitors). Learn more here.

Stay Updated

If you are interested in getting the latest articles from The Blood Project, enter your name and email

  • This field is for validation purposes and should be left unchanged.